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Objective: To identify current clinical status of type 2 diabetic outpatients and to determine the preva-
lence of diabetic complications and risk factors.
Material and method: Prospective cross-sectional study design was used in the data collection process.
The study sample consists of 1077 type 2 Diabetes Mellitus outpatients who ﬁt the inclusion criteria.
All the patients were recruited from the diabetic outpatient clinics from Hospital Universiti Sains Malay-
sia (HUSM). The study period was from January till December 2007. Demographic data, clinical status of
diabetes and its complications were collected and analyzed for the prevalence of complications and risk
factors.
Results: One thousand and seventy seven type 2 diabetes outpatients were included in the present study.
Mean age was 58.3 years and duration of diabetes was 11 years. Only 23.4% of the subjects achieved
HbA1c of 67%, 53.5% of patients had achieved target FPG 66.7 mmol/l, and 60.4% of the patients had
achieved optimal postprandial plasma glucose level <10 mmol/l. The overall prevalence of dyslipidaemia
was 93.7%, hypertension was 92.7% and obesity was 81.5%. Nephropathy was the most common compli-
cation accounting for 91.0% followed by neuropathy 54.4%, retinopathy 39.3%, and macrovascular com-
plications 17.5%. The vascular complications were signiﬁcantly associated with the age (P < 0.001), BMI
(P < 0.001), and triglyceride (P < 0.001).
Conclusion: The prevalence of dyslipidaemia, hypertension and obesity were high. The high prevalence of
vascular complications was associated with age, BMI and triglyceride of diabetic patients. Effort to treat
triglyceride appropriately among elderly diabetic patients could be considered as a prime target.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Type 2 Diabetes Mellitus (DM) is rapidly rising as a global
health care problem that is threatening to reach pandemic levels
by 2030. In 2003, an estimated 194 million adults had diabetes
worldwide (5.1%) [1]. This prevalence increased to 6.0% in 2007,
and is predicted to increase to 7.3% by 2025 [2]. People (380 mil-
lion) are expected to have diabetes in 2025 [2]. In Malaysia, the
Third National Health and Morbidity Survey [3] showed that the
prevalence of type 2 DM for adults aged 30 years and above was
found to be 14.9% in 2006.
The presence of hypertension in diabetic patients has dramati-
cally increased the rate of complication [4]. When happening to-
gether, the two disease entities appear to aggravate one another,ellitus. Published by Elsevier Ltd.
ougalambou).
Oworsening both diabetes and cardiovascular end points [5]. Dyslip-
idaemia is a major risk factor for macrovascular disease. The prev-
alence of dyslipidaemia is increased by at least twofold in the
presence of type 2 DM, and involves all classes of lipoprotein [6].
Obesity is a great public health concern, because it is directly re-
lated to the development of diabetes, hypertension, and ultimately,
congestive heart failure. Overweight adults are more likely to
experience problems, including higher morbidity and mortality [7].
The present study aimed to identify the current clinical status of
type 2 diabetic outpatients in tertiary center and to estimate the
prevalence of vascular complications and other selected risk fac-
tors. The rationale of this study will be to provide suitable baseline
data regarding the current status of type 2 diabetic patients at
HUSM, and the rate of vascular complications among diabetic pa-
tients. Knowing the factors that affect the development of vascular
complications may allow clinicians to draw appropriate plans for
preventing or slowing down the progress of diabetic complications.pen access under CC BY-NC-ND license.
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The medical records were studied either directly from the dia-
betes clinic after the patients consulted the doctors or from the pa-
tient medical record center. The patients selected were type 2
diabetic outpatients, aged over 18 years, with active follow-up at
the diabetic clinic. The exclusion criteria for this study included pa-
tients who were suffering from juvenile diabetes, gestational dia-
betes, thyroid problems, obstructive liver disease, advanced renal
failure, and tuberculosis.
A prospective study was conducted for a study period of one
year (1st January 2007 till 31st December 2007) in order to identify
the characteristics of type 2 diabetic outpatients in a tertiary cen-
ter, and to determine the prevalence of diabetic complications
associated with outpatient diabetic care at HUSM, which is located
in the state of Kelantan, Malaysia. The study design is an observa-
tional, prospective cross-sectional study. Non-probability sampling
method (convenience sample technique) was applied.
The research’s protocol was approved by the Human Research
and Ethics Committee of the School of Medicine in the Universiti
Sains Malaysia. Signed informed consent was obtained from all
patients.Table 1
Demographic characteristics of type 2 diabetic patients.
Variable n (%)
Gender
Male 476 (44.2)
Female 601 (55.8)
Age (years)
635 15 (1.4)
>35–50 194 (18)
>50–65 626 (58.1)
>65 242 (22.5)
Race
Malay 916 (85.1)
Chinese 150 (13.9)
Indian 11 (1.0)
Smoking history
Current smoker 66 (6.1)
Pervious smoker 81 (7.5)
Never smoked 930 (86.4)
Physical activity
Active P150 min/week 471 (43.7)
Non-active <150 min/week 606 (56.3)2.1. Data collection
The outpatient diabetic clinic recording lists of patients who at-
tended the diabetic clinic in HUSMwere captured from the diabetic
clinic registration book. Based on glycaemic control tests (HbA1c,
FPG, PPG), the medical records were then retrieved from the record
ofﬁce using the patient’s name. The medical records review was
undertaken by a single researcher, and the required information
including demographic, co-morbidity characteristics, detailed
physical and biochemical information and therapy to be reviewed
and recorded in a data collection form. Socio-demographic charac-
teristics included age, sex and race, alcohol, smoking history, phys-
ical activity and level of education. Physical examination included:
pulse rate, height, weight and waist circumference. Blood pressure
was measured twice and average reading was taken. Hypertension
was deﬁned as systolic blood pressure of >130 mmHg or diastolic
blood pressure of >80 mmHg or current use of antihypertensive
drugs also has been diagnosed as hypertension [8].
Laboratory results included fasting plasma glucose (FPG), post-
prandial plasma glucose (PPG), HbA1c level, and lipid proﬁle.
Dyslipidaemia was deﬁned as a fasting cholesterol of greater
than 4.5 mmol/l, LDL-C greater than 2.6 mmol/l, Triglyceride great-
er than 1.7 mmol/l, HDL-C less than 1.0 mmol/l in males and less
than 1.3 mmol/l in females [9].
Diabetic retinopathy (DR) was diagnosed with the presence of
retinal hemorrhages, exudates and macular edema [10]. Neuropa-
thy was diagnosed in the presence of persistent numbness, pares-
thesia, loss of hearing of the tuning fork and sense of vibration
[10]. Diabetic nephropathy (DN) was considered by positive persis-
tent proteinuria for at least three consecutive readingsper year, and/
or serum creatinine (SCr) >130 lmol/L and/or GFR <60 ml/min [10].
Coronary artery disease was diagnosed by documented angina
symptoms and conﬁrmed by ECG, or from the results of percutane-
ous transluminal coronary angiography (PTCA) in patient’s records
[11]. Cerebrovascular disease was deﬁned by the presence of tran-
sient ischemic attack or stroke in the past medical history [11].Level of education
<Secondary school 580 (53.9)
PSecondary school 497 (46.1)
Family history
Yes 141 (13.1%)
No 936 (86.9%)2.2. Statistical analysis
Statistical analyses were performed using statistical packages
for social sciences (SPSS) version 12 (SPSS Inc., 2003). Demographic
data were expressed as mean ± SD. Distributions and frequenciesof the independent variable were examined. Data exploration
was undertaken to include descriptive statistics for each variable.
Frequencies and percentages for independent variable were calcu-
lated. In simple logistic analysis, each independent variable was
analyzed to look at any signiﬁcant association with dependent var-
iable (vascular complications) and preceded to by multiple logistic
regressions, to conﬁrm the association after excluding confound-
ers. The results of simple logistic regression analysis were recorded
as beta, P-value, crude odds ratio and 95% conﬁdence interval. Mul-
tivariate analysis was performed on numerical and categorical
analysis variable by using binary logistic regression to eliminate
confounding effect as there are more than one independent vari-
able. The ﬁndings of the ﬁnal model were presented with adjusted
odds ratios (OR), its 95% conﬁdence interval (CI) and corresponding
P-value. The level of signiﬁcance was set at 0.05.3. Results
All type 2 diabetic outpatients who attended diabetic clinic dur-
ing study periods and fulﬁlled the inclusion criteria were selected.
Demographic, health characteristics and clinical variables of all
type 2 diabetic patients included in this study are shown in Tables
1–3.
One thousand and seventy seven type 2 diabetic outpatients
participated in the present study. The age of patients was from
18 to 88, the mean (±SD) age was 58.3 (±9.80) years, and (55.8%)
were female. By assessing the levels of education in patients, those
who had education less than secondary school level constituted
the majority 53.9% of the patients (Table 1).
The mean duration of diabetes was 11 ± 6.81 years, ranging
from less than 1 year to 40 years, and 74.6% had diabetes for more
than 5 years (Table 2).
The mean HbA1c was 8.7% ± 2.3, while mean fasting plasma
glucose levels were 7.8 ± 3.7 mmol/l, and the mean postprandial
plasma glucose levels were 10.0 ± 4.3 mmol/l. The majority of
patients 998 (92.7%) had hypertension, the mean (±SD) systolic
blood pressure (SBP) was 135.9 (±19.78) mmHg and the mean
Table 2
Health characteristics of type 2 diabetic patients.
Variable n (%)
BMI (kg/m2) Asia paciﬁc
Target 623 kg/m2 199 (18.5)
Non-target >23 kg/m2 878 (81.5)
Waist circumference category AP (cm)
Target (male) 690 cm 100 (9.3)
Non-target (male) >90 cm 376 (34.9)
Target (female) <80 cm 50 (4.6)
Non-target (female) P80 cm 551 (51.2)
Diabetes duration (years)
65 years 273 (25.4)
>5–10 years 294 (27.3)
>10–15 years 256 (23.7)
>15–20 years 136 (12.6)
>20 years 118 (11)
HPT duration category (years)
Free from HPT 56 (5.2)
63 years 204 (18.9)
>3–6 years 288 (26.7)
>6–9 years 160 (14.9)
>9 years 369 (34.3)
Table 3
Characteristics of clinical variables of type 2 DM patients.
Variables n (%) Mean (±SD)
HbA1c (%)
Optimal <7% 252 (23.4)
Fair 7–8% 258 (24) 8.72 (±2.34)
Poor >8% 567 (52.6)
Fasting plasma glucose (mmol/l)
Optimal <6.7 mmol/l 498 (46.3)
Fair 6.7–7.8 mmol/l 163 (15.1) 7.89 (±3.72)
Poor >7.8 mmol/l 416 (38.6)
PPG (mmol/l)
Control <10.0 mmol/l 634 (58.9)
Uncontrolled P10.0 mmol/l 443 (41.1) 10.03 (±4.38)
Hypertension control
Systolic blood pressure (mmHg)
6120 mmHg 332 (30.8)
>120–139 mmHg 289 (26.8) 135.98 (±19.78)
140–159 mmHg 296 (27.5)
P160 mmHg 160 (14.9)
Diastolic blood pressure (mmHg)
<80 mmHg 753 (69.9)
80–89 mmHg 33 (3.1) 80.62 (±9.83)
90–99 mmHg 213 (19.8)
>100 mmHg 78 (7.2)
LDL cholesterol (mmol/l) ADA
Normal <2.6 mmol/l 493 (45.7)
Border high 2.6–3.3 mmol/l 285 (26.5)
High 3.4–4.1 mmol/l 186 (17.3) 2.82 (±1.08)
Very high >4.1 mmol/l 113 (10.5)
Total cholesterol (mmol/l) ADA
Target <5.2 mmol/l 681 (63.2) 4.98 (±1.17)
Non-target P5.2 mmol/l 396 (36.8)
Triglycerides (mmol/l) ADA
Normal <1.7 mmol/l 625 (58)
Border high 1.7–2.3 mmol/l 223 (20.7) 1.74 (±0.85)
High 2.4–5.7 mmol/l 229 (21.3)
HDL cholesterol (mmol/l) ADA
Target (male) >1.0 mmol/l (40 mg/dl) 384 (35.7)
Non-target (male) 61.0 mmol/l (640 mg/dl) 92 (8.5) 1.40 (±0.54)
Target (female) >1.3 mmol/l (>50 mg/dl) 348 (32.3)
Non-target (female) 61.3 mmol/l (650 mg/dl) 253 (23.5)
Table 4
Types of vascular complications among type 2 DM patients.
Type of complications n (%)
No complications 48 (4.5)
Microvascular complications 841 (78.0)
Retinopathy 15 (1.4%)
Neuropathy 19 (1.8%)
Nephropathy 273 (25.3%)
Retinopathy, neuropathy 14 (1.3%)
Retinopathy, nephropathy 87 (8.1%)
Neuropathy, nephropathy 221 (20.5%)
Retinopathy, neuropathy and nephropathy 212 (19.6%)
Microvascular and macrovascular complications 188 (17.5%)
Total 1077 (100%)
Table 5
Univariate analysis of risk factors affecting the development of complications.
Variables ba Crude OR (95%CI) P-value
Age 0.14 1.15 (1.11–1.19) <0.001
BMI 0.14 0.86 (0.82–0.90) <0.001
WC 0.05 0.94 (0.92–0.96) <0.001
Duration of diabetes 0.12 1.12 (1.06–1.190 <0.001
HbA1c 0.02 0.97 (0.86–1.09) 0.65
FPG 0.04 1.04 (0.95–1.14) 0.317
PPG 0.09 1.10 (1.01–1.19) 0.027
Triglyceride 0.77 2.18 (1.35–3.50) 0.001
Total cholesterol 0.16 1.18 (0.90–1.54) 0.214
HDL 0.06 0.93 (0.57–1.53) 0.793
LDL 0.06 1.07 (0.81–1.41) 0.630
Systolic blood pressure 0.02 1.02 (1.01–1.04) 0.003
Diastolic blood pressure 0.01 1.01 (0.98–1.04) 0.452
a Simple logistic regression (outcome as complications).
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lipid proﬁle, the mean LDL-C was 2.82 ± 1.08 mmol/l, the mean to-
tal cholesterol was 4.98 ± 1.17 mmol/l, while mean HDL-C was1.40 ± 0.54 mmol/L and mean TG was1.74 ± 0.85 mmol/l.
Non-achievement of the ADA guideline for LDL-C, total cholesterol,
triglycerides, and HDL-C were 54.3%, 36.8%, 42%, and 32%,
respectively (Table 3).
In the aspect of the Metabolic Syndrome, the overall prevalence
of dyslipidaemia was 93.7%, hypertension was 92.7%, and obesity
(BMI >23 kg/m2) was 81.5%.
3.1. Type of vascular complications among type 2 DM patients
Most of the patients, 841 (78%) had microvascular complica-
tions alone, 188 (17.5%) had a combination of microvascular and
macrovascular complications, and of these, 137 (12.8%) had coro-
nary heart disease, only 51 (4.7%) had cerebrovascular disease
and a minority 48 (4.5%) had no complications (Table 4).
Diabetic nephropathy was the most common complication,
accounting for 91.0%, followed by neuropathy 54.4%, retinopathy
39.3%, and macrovascular complications (17.5%).
3.2. Univariate analysis of risk factors affecting the development of
complications
Table 5 shows the simple logistic regression of risk factors
affecting the development of vascular complications. There were
signiﬁcant associations between the complications and age, BMI,
WC, PPG, triglyceride, duration of diabetes and systolic blood
pressure.
3.3. Final model of multivariate analysis on complications
Using a backward stepwise logistic regression, all factors found
to be signiﬁcant at P-value <0.05 during the previous analysis, were
introduced together in one multivariate analysis. Statistically, vari-
Table 6
Factors signiﬁcantly associated with development of complications.
Independent variables ba OR (95.0% CI) P-value
Age 0.13 1.14 (1.10–1.18) <0.001
BMI 0.14 0.86 (0.81–0.91) <0.001
Triglyceride 1.11 3.06 (1.82–5.13) <0.001
Overall correctly classiﬁed percentage = 95.5%. Area under curve = 91.7%.
a Multiple logistic regression.
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the ﬁnal model. These were age, BMI and triglyceride as shown in
Table 6.
4. Discussion
This study undertaken with 1077 diabetic type 2 outpatients is
large enough to evaluate the current status of diabetic patients and
the burden of diabetic complications among Malaysian people at a
tertiary center.
Body mass index and waist circumference were two measure-
ments of obesity in the present study. Looking at current results,
199 (18.5%) of patients had BMI at Asian Paciﬁc target 6 23 kg/
m2 and 878 (81.5%) had non-target BMI. According to Asian Paciﬁc
type 2 DM policy group [9] waist circumference target, a total of
100 (9.3%) male patients were within targets, while 376 (34.9%)
male patients did not achieve targets. A total of 551 (51.2%) female
patients did not achieve the target, while only 50 (4.6%) female pa-
tients achieved the target. Prospective epidemiological studies
showed that waist circumference has been an independent predic-
tor of type 2 DM risk [12,13]. The majority of diabetic patients do
not perform physical activity regularly, and do not adhere to die-
tary advice. Also patients taking oral hypoglycaemic commonly
gain weight due to medication [14].
In the current study 76.6% of the patients did not achieve the
ADA guidelines of HbA1c, 46.5% and 39.6% of patients recruited
in this study had not achieved a target of FPG and PPG levels
respectively.
Dyslipidaemia was found in 93.7% of patients, of which total
cholesterol was more than normal in 36.8%, LDL in 54.3% and tri-
glycerides in 42% but HDL was lower than normal in 32%. A study
by Akbar et al. [15] suggested that poor control was associated
with poor diet compliance and use of multiple medications. Proper
management and control of this disease are needed among elderly
patients.
To achieve glycaemic control, hypertension and dyslipidaemia
the result from this study found that HbA1c achieved the target
in only 24.3% of the patients, 47.2% of patients achieved blood pres-
sure targets and LDL-C of being less than 2.6 mmol/l was achieved
in only 45.8% of all patients, regardless of any treatment strategy;
all of these accounted for an increase in diabetic complications. The
explanation of the result from the present study for the current
state of diabetes may be due to various reasons, like advancing
age, obesity and genetic factors, disease unawareness, socioeco-
nomic status, sedentary life style, long duration of diabetes, intake
of unhealthy food and poor compliance with treatments.
This study has shown a prevalence of macrovascular disease of
17.5% among diabetics and a percentage of macrovascular disease
lower than that in a study in UAE by Al-Maskari et al. [16]. The lat-
ter study found a prevalence of macrovascular disease in 29.5% of
diabetics. The differences in our rates of macrovascular complica-
tions among type 2 DM patients, as compared with others, may
be attributed to the differences in study design and the population
characteristics of various studies.
The present study shows that the prevalence rate of retinopathy
was 39.3%. The prevalence of retinopathy demonstrates wide vari-ations between countries; in type 2 DM it ranges from 17% in
Switzerland to 52% in the United Kingdom [17]. Prevalence of neu-
ropathy was 54.7%, this percentage of neuropathy is higher than
that in a study by Tesfaye et al. [18], who recruited 3250 diabetic
patients and reported the prevalence of neuropathy in 28% of them,
but in other studies it was between 25% and 60% [19,20]. The prev-
alence of nephropathy was 91%. This is considered as a high
percentage in comparison with other studies on diabetic nephrop-
athy which occurs in 40% of diabetic patients [21].
In the present study a high percentage of patients have micro-
vascular rather than macrovascular complications. In comparisons
regarding the prevalence of diabetic microvascular complications,
the study shows that the prevalence of diabetic nephropathy is
more than neuropathy and retinopathy. This may be because the
patients in the current study have hypertension and dyslipidaemia,
which are related to renal complications. In addition, the popula-
tion in this study is Asian, where the prevalence of nephropathy
is more than the other people. This may be due to genetic factors.
Another possible explanation for the high percentage of complica-
tion in the present study is that most of the patients are elderly.5. Conclusion
The prevalence of dyslipidaemia, hypertension and obesity
were high in this population. The unsatisfactory control of meta-
bolic status may be due to age, long duration, obesity and level
of education of diabetic patients.
The rate of vascular complications among type 2 diabetic
patients was high. Identifying factors associated with the develop-
ment of complications would be able to prevent the complications.
From this study, the ﬁndings indicated that age, BMI and triglycer-
ide concentrations are associated with vascular complications.
More attention must be paid to elderly diabetic patients with
appropriate treatment for high triglyceride.
Diabetic patients need more efforts to be spent on them.
Screening and intervention programs should be implemented early
at the diagnosis stage, and risk factors should be treated aggres-
sively. Public health strategies are required in order to improve
the current status of diabetic patients and to decrease the rate of
prevalence of vascular complications.6. Limitation
This analysis was based on type 2 DM clinic at HUSM (tertiary
center); thus data from other centers are required to determine
whether the ﬁnding in this study can be generalised to diabetes
care setting in general. Furthermore the population of this study
was that of diabetic outpatients.
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